Fig. 3
From: Enhancing dendritic cell immunotherapy for melanoma using a simple mathematical model
Simulation of immunotherapy for different amounts of DCs per dose. Interval injection every 168 hours during three weeks and applying 103 DCs per dose (Table 2, Protocol 3), a 19.92 % of decrease was obtained. Tumor population (thick line) and amount of DCs injected (dotted line) are shown
